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Abstract
Introduction
Objective was to examine the temporal variation of HIV sero-discordancy in select represen-
tative countries (Kenya, Lesotho, Mali, Niger, Tanzania, and Zimbabwe) in sub-Saharan
Africa at different HIV epidemic scales. A sero-discordant couple is defined as a stable cou-
ple (SC) in which one partner is HIV-positive while the other is HIV-negative.
Methods
A deterministic compartmental mathematical model was constructed to describe HIV trans-
mission dynamics. The model was pair-based, that is explicitly modeling formation of SCs
and infection dynamics in both SCs and in single individuals. The model accommodated for
different forms of infection statuses in SCs. Using population-based nationally-representa-
tive epidemiologic and demographic input data, historical (1980–2014) and future (2015–
2030) trends of sero-discordancy and other demographic and epidemiologic indicators were
projected throughout HIV epidemic phases.
Results
As the epidemics emerged, about 90% of SCs affected by HIV were sero-discordant. This
proportion declined to 45%-88% at epidemic peak and stabilized as the epidemics started
their natural decline. The largest reductions in sero-discordancy were in high HIV-preva-
lence countries. As the epidemics further declined with antiretroviral therapy (ART) scale-
up, the proportion of sero-discordant couples among HIV-affected couples was projected to
increase to 70%-92% by 2030. The proportion of sero-discordant couples among all SCs
increased as the epidemics emerged and evolved, then peaked at 2%-20% as the epidem-
ics peaked, and then declined as the epidemics declined to reach 0.3%-16% by 2030.
Conclusions
Sero-discordancy patterns varied with the evolution of the epidemics, and were affected by
both epidemic phase and scale. The largest variations were found in high HIV-prevalence
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countries. The fraction of stable couples that are sero-discordant, as opposed to being sero-
concordant positive, was projected to increase with ART scale-up and further HIV incidence
decline over the coming two decades. These findings inform strategic planning and resource
allocation for interventions among sero-discordant couples.
Introduction
Between 35 and 76% of the adult population in sub-Saharan Africa (SSA) live in stable sexual
couples (SCs) [1–4]. Of these couples, 1 to 45% are affected by HIV [2], among whom approxi-
mately one in every two in high HIV-prevalence countries is HIV sero-discordant—that is,
one partner is HIV-positive while the other is HIV-negative [2–4]. HIV incidence in sero-dis-
cordant couples (SDCs) contributes about 30% of all new HIV infections, thus sustaining HIV
epidemics in SSA [2, 5–7], and leading to SDCs becoming a priority population for HIV pre-
vention efforts with a number of demonstrated efficacious interventions among them [5, 8–
10].
Recent research on HIV epidemiology among SCs in SSA provided a mapping of HIV sero-
discordancy patterns [2], and delineated the sources of HIV infection among SCs and their
contribution to incidence [4, 7, 11]. These studies have also demonstrated substantial varia-
tions across countries in the patterns of sero-discordancy [2, 4, 7, 11]. The reasons behind this
variability remain poorly understood. Several potential explanations have been suggested [12,
13]. One of these is HIV epidemic phase (i.e. emergence phase, epidemic-peak phase, and “nat-
ural” epidemic decline phase), and epidemic temporal evolution (that is how the epidemic has
changed over time) considering the rapid changes in incidence and prevalence in much of SSA
over the last two decades [14–16]. Future projections of sero-discordancy over the coming
decades, and of the role of SDCs in the epidemic, are also uncertain, given the expected
changes in incidence and prevalence with the scale-up of interventions—in particular antire-
troviral therapy (ART).
Delineating the historical variation of sero-discordancy with time in Africa’s epidemics
and future projections are therefore critical to inform HIV policy and programming, and
the role that prevention interventions can play for SDCs. Accordingly, we aimed to examine
the temporal variation of sero-discordancy patterns in six representative SSA countries (at
different HIV epidemic scales) using a dynamic pair-based mathematical model—that is a
model that explicitly simulates formation of SCs and infection dynamics in both SCs and in
single individuals, and accommodates for the variability in sexual risk behavior and mixing
in the population. Specifically, we explored historical trends (between 1980 and 2014) and
forecasted future temporal variation (between 2015 and 2030) of key sero-discordancy
indicators.
The overarching aim of our study was to inform our understanding of HIV epidemiology
among SCs, and how the changes in incidence and prevalence are likely to affect epidemiologi-
cal patterns. Furthermore, we aspired to explore the extent to which the variation in sero- dis-
cordancy patterns could be explained by epidemics dynamics.
Methods
We constructed a deterministic compartmental mathematical model of HIV transmission
dynamics based on extension of an earlier model [12]. The model was pair-based simulating
explicitly SC formation and infection transmission in both SCs and in single individuals. The
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model was parameterized using nationally-representative and population-based demographic
and epidemiological measures derived from sources such as the Demographic and Health Sur-
veys (DHS) [17]. All data were already fully anonymized before accessing them. The model
was coded and analyzed in MATLAB R2015a [18]. The MATLAB codes can be obtained by
contacting the authors.
Mathematical model and parametrization
The model consisted of a system of coupled nonlinear ordinary differential equations repre-
senting the movement of individuals between different forms of sexual partnerships and HIV
infection statuses (Fig 1). Model compartments stratify the population based on HIV status,
sexual risk group, engagement in a SC, state of sero-discordancy or sero-concordancy within
the SC, and ART treatment status.
The sexual contact structure accommodates heterogeneity in sexual risk behavior and dif-
ferent forms of mixing between risk groups. The population in reproductive age was stratified
into 10 sexual risk groups representing the variable risk to HIV exposure [19]. This number of
risk groups was included to represent the diversity of sexual risk behavior that exists in a given
population, starting from the lowest level (risk group 1) to the highest level (risk group 10) of
sexual risk behavior. For example, risk group 1 represented the low risk general population
that has the lowest risk of acquiring HIV in a given population. Meanwhile, risk group 10 rep-
resented the high risk populations that have the highest risk of acquiring HIV, such as female
sex workers and their male clients.
The proportion of the population in each risk group was informed by data from SSA on the
distribution of the number of sexual partners over the past year [20]. The population average
level of sexual risk behavior was assumed to vary during the epidemic, based on evidence sug-
gesting substantial declines in the risk of HIV exposure across SSA [16].
We described the mixing between the different sexual risk groups through a mixing matrix.
The matrix incorporated both an assortative component where partners were chosen preferen-
tially from within the same risk group (i.e. a low risk individual choosing a sexual partner also
with low risk), and a proportionate component where partners were chosen with no preferen-
tial bias based on risk group.
Stable couples were divided into SDCs, sero-concordant HIV-negative couples (both part-
ners are sero-negative), and sero-concordant HIV-positive couples (both partners are sero-
positive; Fig 2A). ART scale-up was assumed to start in 2008 and increase at a fixed rate to
reach the country-specific ART coverage in 2014 [21]. The same fixed scale-up rate was
assumed to continue after 2014. ART was assumed to reduce the risk of HIV transmission by
96% based on randomized clinical trial and observational data [10, 22], and to slow the rate of
disease progression by 67% consistent with assumptions of the Joint United Nations Pro-
gramme on HIV/AIDS (UNAIDS) SPECTRUM model [23, 24].
Our model was parameterized using current empirical HIV natural history and epidemiol-
ogy data from SSA, as well as through model fitting for some of the parameters. Parameter val-
ues are described in S1 Table along with their specific sources. These model parameters were
an outcome and distillation of a process through a series of mathematical modeling studies
investigating different aspects of HIV transmission dynamics in SSA [2, 12, 16, 20, 25–27].
HIV prevalence and sero-discordancy data were extracted from DHS databases [17]. HIV
prevalence historical trend data were provided through UNAIDS estimations [28].
Further details on the mathematical model, its structure, and its parametrization can be
found in S1 Text.
Temporal variation of HIV sero-discordancy
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Model fitting
Model predictions were fitted to the country-specific HIV prevalence time series (1990–2014),
and seven country-specific demographic and epidemiologic indicators for each country. The
indicators were: population prevalence of SCs (i.e. marriage rate; Pcouples), population HIV
Fig 1. Flow-chart depicting the basic structure of the used pair-based HIV model.
https://doi.org/10.1371/journal.pone.0196613.g001
Temporal variation of HIV sero-discordancy
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Fig 2. (A) Conceptual diagram illutrating the population in reproductive age by partnership status: not engaged in a stable couple (singles),
sero-concordant HIV-negative stable couple, HIV sero-discordant stable couple, and sero-concordant HIV-positive stable couple. (B)
Characterization of the four generic phases of the HIV epidemics in sub-Saharan Africa. The sero-discordancy patterns in each country were
described and analyzed within the context of these phases of each country’s epidemic.
https://doi.org/10.1371/journal.pone.0196613.g002
Temporal variation of HIV sero-discordancy
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prevalence (P), proportion of couples affected by HIV among all SCs (Ppos), proportion of
SDCs among all SCs with at least one HIV-infected individual in the couple (Pdiscord), propor-
tion of SDCs among all SCs in the population (Pall), proportion of individuals engaged in
SDCs among the entire population in reproductive age (Iall), and proportion of HIV-infected
individuals engaged in SDCs among all HIV-infected individuals (Ipos).
The empirical measures of these indicators were derived from the DHS databases [17], and
then estimated and fitted through the model as described in the S1 Text. A summary of the
definitions, interpretations, and estimations of these key sero-discordancy indicators can be
found in Table 1, and further details can be found in Section D of S1 Text and in Chemaitelly
et al [2].
Plan of analysis
Six countries in SSA representing different HIV epidemic scales were included in our analysis:
low HIV prevalence (Niger and Mali), intermediate HIV prevalence (Tanzania and Kenya),
and high HIV prevalence (Zimbabwe and Lesotho). Country choices were informed by the
availability of sufficient data to characterize the trend in HIV prevalence at the national level,
Table 1. Population-level demographic and epidemiological indicators relating to HIV sero-discordancy by epidemic phase for six countries in sub-Saharan Africa
representing different HIV epidemic scales: Low HIV prevalence (Niger and Mali), intermediate HIV prevalence (Tanzania and Kenya), and high HIV prevalence
(Zimbabwe and Lesotho).
Measure Definition Interpretation Estimation HIV epidemic phase
Emerging
phase
Epidemic
peak
Natural
epidemic
decline phase
Declining
epidemic with
ART§ scale-up
(by 2030)
Pcouples Population prevalence of
SCs
Measures the level of engagement
of individuals in SCs in the
population#
number of individuals in SCs
total number of individuals 51%-84%- 49%-84% 49%-84% 51%-84%
P HIV prevalence in the
population
Measures the level of HIV-infected
individuals in the population#
total number of HIV‐infected individuals
total number of individuals 0.0%-27% 1%-30% 0.5%-28% 0.2%-13%
Ppos Proportion of couples
affected by HIV out of all
SCs
Measures the proportion of SCs
affected by HIV among all SCs in
the population#
number of SCs affected by HIV
total number of SCs
0.0%-40% 2%-41% 1%-37% 0.3%-22%
Ipos Proportion of all HIV-
infected individuals
engaged in a stable
SDCs€
Measures the level of engagement
of HIV-infected individuals in
SDCs
number of HIV‐infected individuals in SDCs
total number of HIV‐infected individuals 21%-67% 15%-63% 17%-60% 31%-68%
Pall Proportion of SDCs
among all SCs in the
population
Measures the level of sero-
discordancy among all SCs in the
population#
number of SDCs
total number of SCs 0.0%-20% 2%-21% 1%-17% 0.3%-16%
Iall Proportion of individuals
engaged in SDCs in the
population
Measures the abundance of
individuals who are engaged in
SDCs in the population#
number of individuals in SDCs
total number of individuals 0.0%-11% 2%-12% 1%-9% 0.2–8%
Pdiscord Proportion of SDCs
among all SCs with at
least one HIV-infected
individual in the couple
Measures the proportion of SCs
affected by HIV where the
uninfected partner is at risk of
acquiring HIV from the infected
partner
number of SDCs
total number of SCs with at least one
HIV‐infected individual in the couple
54%-93% 45%-88% 45%-87% 70%-92%
SC: stable couple.
# population: the entire population in reproductive age (15–49 years old).
§ART: antiretroviral therapy.
€SDC: stable HIV sero-discordant couple.
https://doi.org/10.1371/journal.pone.0196613.t001
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and by the availability of more than one DHS HIV serological biomarker survey. These coun-
tries were also chosen to represent a diversity of epidemic levels (i.e. low, intermediate, and
high). The analysis was conducted at the country level, rather than at the regional level, to uti-
lize the available country-level nationally-representative population-based DHS data. Conse-
quently, sero-discordancy was analyzed in Kenya (DHS 2003 and 2008–09), Lesotho (DHS
2004 and 2009), Mali (DHS 2006 and 2012–13), Niger (DHS 2006 and 2012), Tanzania (DHS
2003–04, 2007–08, and 2012), and Zimbabwe (DHS 2005–06 and 2011).
The HIV epidemic in each country was divided temporally into four phases (Fig 2B): emer-
gence phase as the epidemic started its growth, epidemic-peak phase as the epidemic reached
its highest HIV prevalence, “natural” decline phase as the epidemic started to decline following
the peak level, and ART scale-up phase (future phase) as the epidemic further declined with
high coverage of ART. The natural decline phase was labeled as “natural” to distinguish it from
the subsequent decline with ART scale-up and its high coverage. The exact drivers of the
declines in epidemics over the last two decades or so remain not well-understood [16], and
possibly reflect behavioral changes and natural epidemic dynamics [16]. Sero-discordancy pat-
terns were described and analyzed within the context of these four epidemic phases.
Using the best-fit parameters of the pair-based model for each country, we assessed the his-
torical trends in the following indicators: P, Pcouples, Ppos, Pdiscord, Ipos, Pall, and Iall between 1980
and 2014, the timeframe in which the epidemics emerged, peaked, and naturally declined. We
also examined future trends in these indicators between 2015 and 2030, the timeframe in
which ART had substantial coverage and the epidemics were predicted to decline further.
Results
The discordancy measures that were included in the fitting are listed in S3 Table, while the fit-
ted parameters for each country are listed in S2 Table. The mathematical model fitted HIV
prevalence trends and the rest of the indicators. The various sero-discordancy and other
demographic and epidemiologic indicators showed different variations with epidemic phase,
as summarized in Table 1. The prevalence of SCs (Pcouples) was stable between 1980 and 2030
for all countries (S1 Fig). Pcouples ranged between 51.3% (Lesotho) and 84.4% (Mali).
The proportion of SCs affected by HIV among all SCs (Ppos) varied over time (S3 Fig),
closely following the variation of HIV prevalence in each country (S2 Fig). Early in the epi-
demics, Ppos emerged from 0.0% to between 2% (Niger) and 40% (Zimbabwe). As the epidem-
ics reached their peak, Ppos also peaked at between 2% (Niger) and 41% (Zimbabwe). As the
epidemics started to naturally decline, Ppos declined, following the declines in HIV prevalence.
By 2030, with ART scale-up, between 0.3% (Niger) and 22% (Lesotho) of SCs would be affected
by HIV (S3 Fig).
Fig 3 shows the proportion of HIV-infected individuals in each partnership status (not
engaged in couples (singles), SDCs, and sero-concordant positive couples). The proportion of
infected individuals not engaged in couples was largely stable throughout the epidemics in all
countries. However, this proportion was lower in countries with low HIV prevalence, as mar-
riage rates were higher (S1 Fig). Only 20% of infected individuals were not engaged in couples
in Niger (low HIV-prevalence country) compared to 40% in Lesotho (high HIV-prevalence
country).
The proportion of HIV-infected individuals in SDCs (Ipos) varied with time throughout the
epidemics (Fig 3 and S4 Fig). In the epidemics’ emerging phase, between 21% (Zimbabwe) and
67% (Mali) of infected individuals were in SDCs. As the epidemics evolved and peaked, this
proportion declined to reach a minimum of between 15% (Lesotho) and 57% (Niger). This
proportion remained stable at this level at the epidemics’ natural decline phase. As the
Temporal variation of HIV sero-discordancy
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epidemics declined further with ART scale-up, this proportion increased again to reach
between 31% (Lesotho) and 68% (Niger) by 2030.
The proportion of HIV-infected individuals that are in sero-concordant positive couples
varied also with time throughout the epidemics (Fig 3). In the epidemics’ emerging phase,
between 9% (Kenya) and 36% (Zimbabwe) of infected individuals were in sero-concordant
positive couples. This proportion increased to between 17% (Niger) and 41% (Zimbabwe) as
the epidemics evolved and peaked, and remained then stable in the epidemics’ natural decline
phase. As the epidemics declined further with ART scale-up, this proportion declined to reach
between 11% (Tanzania) and 27% (Lesotho) by 2030.
As the epidemics emerged, the proportion of SDCs among all SCs with at least one HIV-
infected individual in the couple (Pdiscord), the most important indicator of sero-discordancy,
started at about 90% (Fig 4). As the epidemics evolved and peaked, Pdiscord ranged between
45% (Zimbabwe) and 88% (Niger), and then stabilized during the epidemics’ natural decline
phase. As the epidemics declined further with ART scale-up, Pdiscord increased to between 70%
(Lesotho) and 92% (Niger) by 2030. The variation in Pdiscord with epidemic phase was more
pronounced with higher HIV prevalence. For example, as the epidemics evolved, Pdiscord in
Fig 3. Model predicted proportion of HIV-infected individuals by partnership status: Not engaged in stable couple, sero-discordant stable
couple, and sero-concordant positive stable couple. Countries are shown in order of increasing HIV prevalence. (A) Niger, (B) Mali, (C)
Tanzania, (D) Kenya, (E) Zimbabwe, and (F) Lesotho.
https://doi.org/10.1371/journal.pone.0196613.g003
Temporal variation of HIV sero-discordancy
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Zimbabwe, a high HIV-prevalence country, declined from 90% to 45% (Fig 4E), while Pdiscord
in Niger, a low HIV-prevalence country, declined slightly from 91% to 85% (Fig 4A).
The proportion of SDCs among all SCs (Pall) was low early in the epidemics and increased
as the epidemics expanded, peaking around the same year that HIV prevalence peaked (S5
Fig). The peak value of Pall ranged between 2% (Niger) and 21% (Zimbabwe). As the epidemics
started their natural decline, Pall declined, following also the decline in HIV prevalence (S2
Fig). As the epidemics declined further with ART scale-up, Pall increased slightly in high HIV-
prevalence countries (Panels E and F in S5 Fig), and then declined again with further decline
in HIV prevalence. By 2030, Pall ranged between 0.3% (Niger) and 16% (Lesotho).
The proportion of individuals engaged in SDCs among the entire population in reproduc-
tive age (Iall; S6 Fig) closely followed the trends of Pall (S5 Fig) and HIV prevalence (S2 Fig). In
the epidemics’ emerging phase, Iall emerged from 0.0% to between 1% (Niger) and 11% (Zim-
babwe). As the epidemics evolved and peaked, Iall peaked at 2% (Niger) to 12% (Zimbabwe).
As the epidemics started their natural decline, Iall declined, following also the decline in Pall
and HIV prevalence. As the epidemics declined further with ART scale-up, Iall increased
slightly in high HIV-prevalence countries (Panels E and F in S6 Fig), and then declined again
Fig 4. Model predicted proportion of stable HIV sero-discordant couples among all stable couples with at least one HIV-infected
individual in the couple (Pdiscord) for six representative countries in sub-Saharan Africa. Countries are shown in order of increasing HIV
prevalence: (A) Niger, (B) Mali, (C) Tanzania, (D) Kenya, (E) Zimbabwe, and (F) Lesotho. The black lines show model predictions while the red
asterisks show Demographic and Health Surveys data points and their 95% confidence interval [17].
https://doi.org/10.1371/journal.pone.0196613.g004
Temporal variation of HIV sero-discordancy
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with further decline in HIV prevalence. By 2030, Iall was projected to range between 0.2%
(Niger) and 8% (Lesotho).
S7 Fig highlights the impact of ART scale-up on Pdiscord. The figure shows Pdiscord with
ART scale-up compared to a counter-factual scenario of no-ART scale up, in Kenya as an illus-
trative example. The temporal variation of Pdiscord was sensitive to ART coverage, and Pdiscord
increased steadily as ART was scaled up. The temporal variation of Ipos was also sensitive to
ART coverage, while the impact of ART scale-up was rather limited on Ppos, Pall, and Iall (not
shown). While the impact of ART scale-up is shown here only for Kenya, similar patterns were
observed in the other countries.
Discussion
The patterns of sero-discordancy in SSA and the role of SDCs in the epidemics have been sub-
ject of debate [29–31]. The debate was centered on data derived from cross-sectional surveys
at specific points of time, mostly post the year 2000. We presented here, however, a compre-
hensive analysis of different sero-discordancy indicators throughout the epidemics’ phases,
and projected the indicators’ variation into the future as the epidemics further decline with
ART scale-up.
Our results indicated that sero-discordancy patterns varied with the epidemics’ evolution,
reflecting rich infection dynamics. Our findings demonstrated that cross-sectional measures
of sero-discordancy reflect only snapshots that are not necessarily representative, and that
these snapshots may lead to misinterpretations about the role of SCs in HIV epidemiology.
Proper understanding of sero-discordancy epidemiology cannot be accomplished without fac-
toring the time dimension. This comes in contrast with the spatial dimension, which turned
out to contribute minimally to understanding sero-discordancy epidemiology and its patterns
[32] These findings corroborate earlier studies suggesting that HIV epidemiology among SCs
appears to be a predictable “spill-over” effect of the “core” HIV dynamics in the population [2,
4, 7, 11, 33], and accordingly is affected by change in epidemic phase.
One of the consistently observed patterns in cross-sectional data is that the fraction of
SCs affected by HIV that are sero-discordant as opposed to being sero-concordant positive
(Pdiscord), is much higher in low HIV-prevalence than in high HIV-prevalence countries [2]
Our results demonstrated that this pattern is largely temporal in nature, and emerged only
because these cross-sectional data were collected when Pdiscord was at its nadir as the epidemics
started their natural decline (Fig 4).
A variation and compensation pattern, between sero-discordant versus sero-concordant
positive SCs, was evident throughout the epidemics (Fig 3). Historically, even in high HIV-
prevalence countries, Pdiscord was very high (around 90%) early in the epidemics when HIV
transmission was focused primarily in high-risk populations. At this time, with HIV incidence
among those aged 15–24 being substantial, many young individuals acquired the infection
through premarital sex, but then married negative partners and formed new SDCs. Others,
who were already in SCs, brought the infection into the partnership through extramarital sex,
thereby also forming new SDCs. As the epidemics expanded into the general population and
reached their peaks (in the 1990s), many of these SDCs were becoming sero-concordant posi-
tive as the infected index partners passed the infection to their spouses.
As HIV incidence rate started to decline, existing SDCs became sero-concordant positive
at a faster rate than partnerships became SDCs—the risk of acquiring the infection through
extramarital sex was declining, and there were less young individuals being infected through
premarital sex to marry and form new SDCs. With this imbalance in more SDCs becoming
sero-concordant positive, and less SDCs being formed, half of SCs affected by HIV in high
Temporal variation of HIV sero-discordancy
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HIV-prevalence countries became sero-concordant positive (Fig 3). As we move into the
future with high ART coverage over the coming two decades, many of the sero-concordant
positive SCs would have been dissolved due to disease mortality of one or both of the partners,
or because of partnership dissolution. With ART treatment also, infected index partners in
SDCs are less likely to transmit the infection to their spouses. These trends will result in the
vast majority of partnerships affected by HIV being sero-discordant, in both high and low
HIV-prevalence countries. The ART era will bring Pdiscord back to its high historical levels
when the epidemics emerged (Fig 4).
The variations in sero-discordancy indicators were found to be more pronounced in high
HIV-prevalence countries, given the larger variation in epidemic scale across the different epi-
demic phases (Figs 3 and 4 and S3–S6 Figs). Our results also indicated that at epidemic peak,
very large fraction of SCs were affected by HIV in the high HIV-prevalence countries (S3 Fig).
As much as 40% of SCs in Lesotho and Zimbabwe were affected by HIV, with one or both part-
ners being infected, highlighting the severity of these epidemics at that time even in the general
population of married individuals. As the epidemics further decline with ART scale-up over
the next two decades, fewer couples will be affected by HIV, but still 10–20% of couples in the
high HIV-prevalence countries will remain affected.
Our results further suggested that the prevalence of SCs (marriage) has been largely stable
despite AIDS mortality, even in high HIV-prevalence countries (S2 Fig). Moreover, the frac-
tion of infected individuals who are not part of a SC has been also overall stable, and was
higher with higher HIV prevalence (Fig 3). As much as 40% of infected individuals are not in
SCs in Lesotho and Zimbabwe. This outcome is a consequence of the lower average age at
infection in high HIV-prevalence countries—many young individuals acquire the infection
before getting married. Disease mortality also contributed to this outcome, though modestly,
as a fraction of SCs were dissolved due to death of one of the partners.
Though we used a complex mathematical model structure to capture the complexity of
HIV dynamics among SCs, our predictions may depend on the type of mathematical model
used in the analyses. Our analyses are also limited by the quality and precision of available
data. DHS data are quality population-based and nationally-representative data, but have a
number of inherent limitations [2, 12]. Despite these potential sources of limitations, our
model fitted measured sero-discordancy and other indicators across the countries (Fig 4 and
S1–S6 Figs).
Conclusions
SDCs are a key population for HIV prevention, and several interventions with proven efficacies
can benefit them. However, sero-discordancy patterns varied with time with the evolution of
the epidemics, and were affected by both epidemic phase and scale. The largest variations in
sero-discordancy were found in high HIV-prevalence countries. The fraction of SCs that are
sero-discordant, as opposed to being sero-concordant positive, was projected to increase with
ART scale-up and further HIV incidence decline over the coming two decades. These findings
inform strategic planning and resource allocation for intervention programming among SDCs.
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